BioNTech SE

@BioNTech_Group

We aspire to individualize cancer medicine by pioneering the next generation of patient-specific immunotherapies

Vrijeme pridruživanja: studeni 2018.

Tweetovi

Blokirali ste korisnika/cu @BioNTech_Group

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioNTech_Group

  1. 16. sij

    We are excited to announce that we have entered into a definitive under which we will acquire to strengthen our position in T . Read more here:

    Poništi
  2. 15. sij

    Yesterday our CBO & CCO Sean Marett discussed the future of cell & gene therapies at the highlighting the importance of manufacturing of -based therapies.That is why we are in the process of further expanding our in-house capabilities in the next years

    Poništi
  3. 13. sij

    We are excited to announce the of Ryan Richardson as Chief Strategy Officer and Managing Director. Ryan will support us in our long-term to become a company. Read the full PR here:

    Poništi
  4. 10. sij

    Meet Sean Marett, our CBO & CCO at the on January 14, 2020, in San Francisco, where he will discuss the future of & on a panel at 8.00 am PT

    Poništi
  5. 7. sij

    Interested in European biotech companies? We are happy to be named one of the 20 European companies to follow this year. consulted with experts to identify the companies across all areas of biotech. #2020 Check out the entire list:

    Poništi
  6. 2. sij

    Preclinical PoC data on our first solid program BNT211 were published in the current issue of . Read the full paper on how we aim to overcome the existing hurdles and create an efficient approach with our CARVac technology here

    Poništi
  7. 18. pro 2019.

    We announced a €50M financing from to advance R&D, market access and manufacturing development of our most advanced treatments under development.

    Poništi
  8. 5. pro 2019.

    We are on top in ’s ranking of the 10 best immuno-oncology start-ups of 2019. Thanks for including us!

    Poništi
  9. 20. stu 2019.

    Read more about our Özlem Türeci in special report on 20 extraordinary in . Özlem is one of many women at who support our vision.

    Poništi
  10. 20. stu 2019.

    Proud to be named company of the year at this year’s , big thanks to the BioNTech family!

    Poništi
  11. 20. stu 2019.

    Congrats to our CEO Ugur on receiving the in the category private CEO of the year from

    Poništi
  12. 14. stu 2019.

    Today we announced our third quarter financial report, the first as a public company, detailing our progress for the year to date. Looking for the full report? Click here:

    Poništi
  13. proslijedio/la je Tweet
    11. stu 2019.

    "We're a Germany company. We think long-term." Sean Marett

    Poništi
  14. proslijedio/la je Tweet
    11. stu 2019.

    “Anyone who tells you that building a biotech company in Europe is easy is mistaken.” — Sean Marett, COO of at the panel: "Funding Trends and How to Break Them"

    Poništi
  15. 15. lis 2019.

    We are excited to announce the launch of our new website. We believe that our approach to treating cancer is unique. So is BioNTech as a company. Hence, our employees represent the face(s) of our new website. Take a look at:

    Poništi
  16. 11. lis 2019.

    We are proud to announce that BioNTech is now officially . This is an important step on our journey to individualize cancer medicine globally.

    Poništi
  17. 10. lis 2019.

    It’s official! First day of trading begins for on Thursday, October 10th at 9:30am ET (3:30pm CET)

    Poništi
  18. 9. srp 2019.

    We are excited to announce the closing of a $325M round, one of the largest private events for a company to advance our medicine pipeline. See full press release here:

    Poništi
  19. proslijedio/la je Tweet
    26. lip 2019.

    Fireside chat with VP Business Alliances Holger Kissel of - "How to close a high-value drug development deal?"

    Poništi
  20. 24. lip 2019.

    BioNTech CBO/CCO, Sean Marett, is featured on our collaborator's website discussing advances in the -immunity cycle. Click here to read about how together we are individualizing with innovative vaccines & technology:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·